BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30677457)

  • 1. The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.
    Gonzalez AN; Lipsky MJ; Li G; Rutman MP; Cooper KL; Weiner DM; Badalato G; Decastro GJ; Wenske S; McKiernan JM; Anderson CB
    Urology; 2019 Apr; 126():34-38. PubMed ID: 30677457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of cystoscopy as an initial diagnostic modality for asymptomatic microscopic hematuria.
    Hong SK; Ahn C; Kim HH
    J Korean Med Sci; 2001 Jun; 16(3):309-12. PubMed ID: 11410691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of asymptomatic microscopic hematuria in adults.
    Sharp VJ; Barnes KT; Erickson BA
    Am Fam Physician; 2013 Dec; 88(11):747-54. PubMed ID: 24364522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms.
    Wu JM; Williams KS; Hundley AF; Jannelli ML; Visco AG
    Am J Obstet Gynecol; 2006 May; 194(5):1423-6. PubMed ID: 16579943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
    Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
    Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can reproductive characteristics predict bladder cancer in women with haematuria?
    Yavuzcan A; Caglar M; Kayikci MA; Basaran E; Tekin A; Ozdemir E; Dilbaz S; Ustun Y; Cam HK
    Asian Pac J Cancer Prev; 2013; 14(9):5107-10. PubMed ID: 24175784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center.
    Commander CW; Johnson DC; Raynor MC; Burke LM; Hacker KE; Hoag B; Fielding JR; Semelka RC; Lee ER
    Urology; 2017 Apr; 102():31-37. PubMed ID: 28088432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
    Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
    World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract.
    Ordell Sundelin M; Jensen JB
    Scand J Urol; 2017 Oct; 51(5):373-375. PubMed ID: 28644736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.
    Pak JS; Wang EY; Lee K; Pina LA; McKiernan JM; Anderson CB
    Urol Oncol; 2021 May; 39(5):300.e1-300.e6. PubMed ID: 33339726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of computed tomographic urography for the detection of bladder tumors in patients with microscopic hematuria.
    Aguilar-Davidov B; Ramírez-Muciño A; Culebro-García C; Sotomayor M; Castillejos-Molina R; Feria-Bernal G; Rodríguez-Covarrubias F
    Actas Urol Esp; 2013; 37(7):408-11. PubMed ID: 23398811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria.
    Trojan B; Tang A; Chandrapal J; Filleur S; Nelius T
    Ren Fail; 2013; 35(1):72-6. PubMed ID: 23151051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic evaluation of patients presenting with hematuria: An electronic health record-based study.
    Richards KA; Ruiz VL; Murphy DR; Downs TM; Abel EJ; Jarrard DF; Singh H
    Urol Oncol; 2018 Mar; 36(3):88.e19-88.e25. PubMed ID: 29169843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
    Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
    Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.
    Loo RK; Lieberman SF; Slezak JM; Landa HM; Mariani AJ; Nicolaisen G; Aspera AM; Jacobsen SJ
    Mayo Clin Proc; 2013 Feb; 88(2):129-38. PubMed ID: 23312369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
    Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
    Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    Ngo B; Papa N; Perera M; Bolton D; Sengupta S
    BJU Int; 2017 May; 119 Suppl 5():19-25. PubMed ID: 28544302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.